A Single-arm, Open-label, and Multicenter Phase Ⅱ Study Designed to Evaluate the Efficacy and Safety of Rulonilimab Combined With Chemotherapy in Patients With Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
Latest Information Update: 28 Feb 2023
At a glance
- Drugs Rulonilimab (Primary) ; Carboplatin; Paclitaxel; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Shandong New Time Pharmaceutical Co LTD
Most Recent Events
- 28 Feb 2023 New trial record